Who
In numbers
- Trades disclosed
- 15
- Buys
- 1
- Sells
- 0
- Bought
- $20K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Jan 2022
- Last trade
- 7 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —22,815 at $0.00 | filing |
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —22,815 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —30,157 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —33,505 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —33,505 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —30,157 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,509 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —8,216 at $0.00 | filing |
| 2 Oct 2024filed 4 Oct 2024 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —8,639 at $0.00 | filing |
| 27 Aug 2024filed 29 Aug 2024 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —23,172 at $0.00 | filing |
| 1 Jan 2024filed 3 Jan 2024 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —108,333 at $0.00 | filing |
| 2 Jan 2023filed 4 Jan 2023 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —89,041 at $0.00 | filing |
| 13 Jan 2022filed 18 Jan 2022 | ENTX Entera BioBiotechnology | SEC FORM 4 Bought | $20K7,232 at $2.74 | filing |
| 1 Jan 2022filed 14 Jan 2022 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —35,852 at $0.00 | filing |
| 1 Jan 2022filed 14 Jan 2022 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —107,557 at $0.00 | filing |
News
Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual MeetingENTX · manilatimes.net · 8 Oct 2026
0 headlines in the last 90 days name Yonatan Malca; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.